Q&A With Mary Norine Walsh From St. Vincent Hospital: New Therapies Provide Hope for Heart Failure Patients

Video

With the introduction of two new medications cardiologists have powerful new tools to use in order to help heart failure become an even more manageable condition.

With the introduction of two new medications cardiologists have powerful new tools to use in order to help heart failure become an even more manageable condition.

Mary Norine Walsh, MD, from St. Vincent Hospital in Indianapolis discussed these new options as well as other areas of interest for the condition during the European Society of Cardiology's annual conference in London. In addition to her duties at the hospital Walsh also serves as the Vice President of the American College of Cardiology.

Whether it is the general practitioner, the cardiologist, or the cardiac surgeon, the landscape of heart failure treatment is constantly changing. Because of this learning remains an important factor in daily practice.

New medications and treatments for heart failure have been developed over the past couple of decades but there is still more work to be done. This includes improving existing technology and also adding new tools in the fight against the condition.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.